Effect of levomepromazine on EEG and on clinical side effects after lumbar myelography with metrizamide.
In patients with lumbago-sciatica levomepromazine is a potent supplement to analgetics in pain treatment. The hypothesis that neuroleptics increase the risk of epileptic seizures after metrizamide myelography was not confirmed in a series of 77 patients, 26 with and 51 without levomepromazine medication, before and after lumbar metrizamide myelography. No differences existed between the groups with regard to the appearance of EEG abnormalities such as slow waves or spikes. Mild side effects were more frequent in the levomepromazine group, except nausea and vomiting. Lumbar metrizamide epidurography in 30 patients did not cause any abnormal EEG.
D004347:Drug Interactions; D004569:Electroencephalography; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008728:Methotrimeprazine / Q000009:adverse effects*; D008793:Metrizamide / Q000009:adverse effects*; D009192:Myelography / Q000009:adverse effects; D009325:Nausea / Q000139:chemically induced; D012585:Sciatica / Q000000981:diagnostic imaging / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced; D013997:Time Factors
D008728:Methotrimeprazine; D008793:Metrizamide